Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference

EMERYVILLE, Calif., Nov. 11  /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time).  Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software.  For those unable to participate during the live webcast, a recorded replay of the presentation will be available one hour following the conclusion of the presentation through December 18, 2009.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer.  The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar®, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer.  Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types.  For more information about Onyx, visit the company's website at http://www.onyx-pharm.com/.

Nexavar® (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals. 

DATASOURCE: Onyx Pharmaceuticals, Inc.



CONTACT:  Alex Santos of Onyx Pharmaceuticals, Inc., [phone]



Web Site:  http://www.onyx-pharm.com/ 

Copyright